Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells

Cancer Research

Volumn 57, Issue 3, 1997, Pages 476-480

  Iversen, Per O ^a   Hart, Prue H ^b   Bonder, Claudine S ^b   Lopez, Angel F ^a  

^a Rundle Mall   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MYELOMONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, CD; CELL SURVIVAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4;

EID: 0031059393     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Castro-Mulaspina, H., Schaison, G., Passe, S., Pasquier, A., Berger, R., Bayle-Weisgerber, C., Miller, D., Seligmann, M., and Bernard, J. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer (Phila.), 54:675-686, 1984.
2. Castleberry, R. P., Emanuel, P. D., Zuckerman, K. S., Cohn. S., Strauss, L., Byrd, R. L., Homans, A., Chaffee, S., Nitschke, R., and Gualtieri, R. J. A pilot study of isoretinoin in the treatment of juvenile chronic myelogenous leukemia. N. Engl. J. Med., 331:1680-1684, 1994.
3. Sanders, J. E., Buckner, C. D., Thomas, E. D., Fleischer, R., Sullivan, K. M., Appelbaum, F. A., and Storb, R. Allogeneic marrow transplantation for children with juvenile chronic myelogcnous leukemia. Blood, 71:1144-1146, 1988.
4. Chan, H. S. L., Estrov, Z., Weitzman, S. S., and Freedman, M. H. The value of intensive combination chemotherapy for juvenile chronic myelogeneous leukemia. J. Clin. Oncol., 5:1960-1967, 1987.
5. Kaplinsky, C., Lotem, J., and Sachs, L. Protection of human myeloid leukemic cells against doxorubicin-induced apoptosis by granulocyte -macrophage colony-stimulating factor and interleukin 3. Leukemia (Baltimore), 10:460-465, 1996.
6. Emanuel, P. D., Bates, L. J., Zhu, S-W., Castleberry, R. P., Gualtieri, R. J., and Zuckerman, K. S. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp. Hematol., 19:1017-1024, 1991.
7. Gualtieri, R. J., Emanuel, P. D,. Zuckerman, K. S., Martin, G., Clark, S. C., Shadduck, R. K., Dracker, R. A., Akabutu, J., Nitschke, R., Hetherington, M. L., Dickerman, J. D., Hakami, N., and Castleberry, R. P. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood, 74:2360-2367, 1989.
8. Emanuel, P. D., Bates, L. J., Castleberry, R. P., Gualtieri, R. J., and Zuckerman, K. S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hemalopoietic progenitors. Blood, 77:925-929, 1991.
9. Freedman, M. H., Cohen, A., Grunberger, T., Bunin, N., Luddy, R. E., Saunders, E. F., Shahidi, N., Lau, A., and Estrov, Z. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogeneous leukaemia. Br. J. Haematol., 80:40-48, 1992.
10. Ivereen, P. O., Rodwell. R. L., Pitcher, L., Taylor, K. M., and Lopez, A. F. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood. 88:2634-2639, 1996.
11. Schiro, R., Longoni, D., Rossi, V., Maglia, O., Doni, A., Arsura, M., Carrara, G., Masera, G., Vannier. E., Dinarello, C. A., Rambaldi, A., und Biondi, A. Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist. Blood, 83:460-465, 1994.
12. Bagby, Jr., G. C., Dinarello, C. A., Neerhout, R. C., Ridgway, D., and McCall, E. Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J. Clin. Invest., 82:1430-1436, 1988.
13. Attias, D., Grunberger, T., Vanek, W., Estrov, Z., Cohen, A., Lau, R., and Freedman, M. H. B-lineage lymphoid blast crisis in juvenile chronic myelogeneous leukemia:II. Interleukin-1-mediated autcrine growth regulation of the lymphoblasts. Leukemia (Baltimore), 9: 884-888, 1995.
14. Howard, M., and O'Garra, A. Biological properties of interleukin 10. Immunol. Today, 13:198-200, 1992.
15. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes:an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174: 1209-1220, 1991.
16. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol., 153:811-816, 1994.
17. Bogdan, C., Paik, J., Vodovotz, Y., and Nathan, C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin 10. J. Biol. Chem., 207:23301-23308, 1992.
18. 2. Proc. Natl. Acad. Sci. USA, 50: 3803-3807, 1989.
19. te Velde, A. A., Huijbens, R. J. F., Heije, K., de Vries, J. E., and Figdor, C. G. Interleukin-4 (IL-4) inhibits secretion of IL-Iβ, tumor necrosis factor α. and IL-6 by human monocytes. Blood, 76:1392-1397, 1990.
20. Essner, R., Rhoades, K., McBride, W. H., Morton, D. L., and Economou, J. S. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Biol. Chem., 142:3857-3861, 1989.
21. de Waal Melefyt, R., Figdor, C. G., Huijbcns, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W,. Zurawiki, G., and de Vries, J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol., 151:6370-6381, 1993.
22. + cells into the myeloid lineage. Blood, 80:1405-1412, 1992.
23. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytomeuy. J. Immunol. Methods. 139:271-279, 1991.
24. Quentmeier, H., Kolsdorf, K., Zaborski, M., and Drexler, H. G. IL-4R α and γ chain expression in LPS- and IL-4-stimulated MONO-MAC-6 cells. Leukemia (Baltimore). 9:336-340, 1995.
25. Hilton, D. J., Zhang, J, G., Metcalf, D., Alexander, W. S., Nicola, N. A., and Willson, T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA, 93:497-501, 1996.
26. Largaespada, D. A., Brannan, C. I., Jenkins, N. A., and Copeland., N. G. Nf1 deficiency causes ras-mediated granulocyte-macropahge colony-stimulating factor hypersensitivity and chronic leukaemia. Nat. Genet., 12:137-143, 1996.
27. Bollag, G., Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F., Jacks, T., and Shannon, K. Loss of NF1 results in activation of the ras signaling pathway and leads to abberant growth in haematopoietic cells. Nat. Genet., 12:144-148, 1996.
28. Satoh, T., Nakafuku, M., Miyajima, A., and Kaziro, Y. Involvement of ras p21 protein in signal-transduciion pathways from interleukin 2, interleukin 3, and granulocyte/ macrophage colony-stimulating factor, but not from interleukin 4. Proc. Natl. Acad. Sci. USA, 55:3314-3318, 1991.
29. Miyauchi, J., Asada, M., Sasaki, M., Tsunematsu, Y., Kojima, S., and Mizutani, S. Mutations of the N-ras gene in juvenile chronic myetogenous leukemia. Blood, 83:2248-2254, 1994.
30. ras. Blood, 84:3435-3439, 1994.
31. Lang, R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G., Williamson, D. J,. Klintworth, G. K., Gonda, T. J., and Dunn, A. R. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell. 51:675-686, 1987.
32. Wong, H. L., Lotze, M. T., Wahl, L. M., and Wahl, S. M. Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J. Immunol., 148:2118-2125, 1992.
33. Chanez, P., Vignola, A. M., Paul-Eugene, N., Dugas, B., Godard, P., Michel, F. B., and Bousquet, J. Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma. J. Allergy Clin, Immunol., 94:997-1005, 1994.
34. Schreiber, S., Heinig, T., Panzer, U., Reinking, R., Bouchard, A., Stahl, P. D., and Raedler, A. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology, 108:21-33, 1995.
35. Hart, P. H., Ahern, M. J., Jones, C. A., Jones, K. L., Smith, M. D., and Finlay-Jones, J. J. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J. Immunol., 151:3370-3380, 1993.
36. Hart, P. H., Ahern, M. J., Smith, M. D., and Finlay-Jones, J. J. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol., 99:331-337, 1995.
37. Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., and Dinarello, C. A. A randomized, controlled trial of IL-10 in humans. J. Immunol., 154:5492-5499, 1995.
38. Huhn, R. D., Radwanski, E., O'Connell, S. M., Sturgill, M. G., Clarke, L., Cody, R. P., Affrime, M. B., and Cutler, D. L. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood, 87:699-705, 1996.
39. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. Interleukin (IL)-IO inhibits nuclear factor κB (NFκB) activation in human monocytes. J. Biol. Chern., 270:9558-9563, 1995.